[1]
“To Evaluate The Use Of Ivabradine In Prevention Of Hemodynamic Response To Laryngoscopy And Intubation”, Journal of Pharmaceutical Negative Results, pp. 388–398, Jul. 2023, doi: 10.47750/pnr.2023.14.04.47.